NIH HIV Experts Prioritize Research to Achieve Sustained ART-Free HIV Remission | NIH: National Institute of Allergy and Infectious Diseases

NIH HIV Experts Prioritize Research to Achieve Sustained ART-Free HIV Remission | NIH: National Institute of Allergy and Infectious Diseases

Thursday, June 6, 2019 NIH HIV Experts Prioritize Research to Achieve Sustained ART-Free HIV Remission Achieving sustained remission of HIV without life-long antiretroviral therapy is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.